RSS   Newsletter   Contact   Advertise with us
Post Online Media

Codiak BioSciences names VP and head of clinical development

Codiak BioSciencesCodiak BioSciences, a developer of exosome for therapeutics and cancer diagnoses, announced the appointment of Benny Sorensen as VP and head of clinical development.

Dr. Sorensen joined Codiak from Alnylam Pharmaceuticals, where he was Senior Director of Clinical Research since 2013 leading preclinical as well as clinical, regulatory, medical affairs and commercial development strategies for hematology products.

Article continues below

READ MORE VPG appoints Cary Wood to its board of directors

Dr. Sorensen has more than 15 years of experience in clinical and translational research and management.

Before joining Alnylam, Dr. Sorensen was a Global Medical Director at Baxter Healthcare Corporation advancing phase three pivotal development of Adynovate and Vonvendi.

Prior to Baxter he was the Director of the Haemostasis Research Unit and Honorary Lecturer at Guy’s and St. Thomas’ Hospital & King’s College London School of Medicine, where he led basic translational research and advancement of several clinical trials across Phases I, II, and III.

Dr. Sorensen has published extensively in hematology translational and clinical research.




What to read next



 LATEST MOVES FROM Massachusetts 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy